Why Is Nirsevimab So Expensive?(And How to Pay $421 Instead)
Nirsevimab averages $495/month at US retail. Through Script Unlock pharmacy bidding, the same prescription typically costs $421/month. Here's exactly why retail is so high — and how to stop paying it.
5 Real Reasons Nirsevimab Costs So Much
Patent Protection
Nirsevimab has active patent protection, giving the manufacturer a legal monopoly. With no generic competitor, they set any price they want. Patent lifecycles run 20 years from filing, often extended through minor reformulations or pediatric exclusivity.
PBM Spread Pricing
Pharmacy benefit managers (PBMs) sit between insurance plans and pharmacies. PBMs charge plans a higher price and pay pharmacies less — pocketing the spread. For high-volume drugs like Nirsevimab, this spread can be substantial. You see it as your copay; the PBM books it as profit.
Manufacturer Pricing Power
Nirsevimab's manufacturer sets the wholesale acquisition cost (WAC) — the "list price" — independent of production costs. US drug prices are not regulated at the federal level. WAC for Nirsevimab has risen above the general inflation rate for the past decade, driving up both copays and uninsured cash prices.
Insurance Tier System
Insurance formularies place Nirsevimab on a tier. Higher tiers mean higher copays — and tier placement depends partly on rebate deals between PBMs and the manufacturer, not on clinical evidence. If your plan assigns Nirsevimab to tier 3 or higher, you absorb the cost of that negotiation.
Pharmacy Margin Variance
Pharmacies set their own cash prices for Nirsevimab. National chains target 30–40% margins using insurance reimbursement formulas even for cash patients. Independents often accept lower margins to win volume. Same Nirsevimab script — $421 at one pharmacy, $495 at another, two miles apart.
The Middlemen Taking a Cut of Nirsevimab
Between the factory and your medicine cabinet, 5 parties each take a margin on every $495 you pay.
Script Unlock removes the PBM from the chain and lets pharmacies compete directly — collapsing the markup stack.
Nirsevimab Price Has Risen ~186% Since 2016
Estimated average US retail price trend for Nirsevimab over the past decade.
Historical estimates based on CMS NADAC data and PBM rate trends. Actual price growth varies by Nirsevimab dose and formulation.
What You Can Do Right Now
5 actions that take under 10 minutes — most patients achieve the full 15% saving off Nirsevimab retail.
- 1Compare cash prices via Script Unlock pharmacy bidding — Nirsevimab bids average $421/month (15% below the $495 retail).
- 2Ask your prescriber about generic Nirsevimab-alip. Same FDA-approved molecule, typically 70–90% cheaper than brand-name Nirsevimab.
- 3Request a 90-day supply of Nirsevimab instead of monthly. Typical saving: 10–15% per fill.
- 4Check Nirsevimab manufacturer patient assistance. If your income qualifies, the medication may be free or deeply discounted.
- 5Compare your insurance copay to the cash price every refill. For Nirsevimab, many patients pay less cash than their copay — especially before hitting the deductible.
“I was paying $495/month until I found pharmacy bidding”
“I’d been filling Nirsevimab at the same chain for two years — $495 every month without question. I assumed that was just what it cost. My insurance covered some of it, but not enough. Then I uploaded the prescription to Script Unlock. Within five minutes I had four bids: $421, $$425, $$430, and $$347. The cheapest was an independent pharmacy I’d driven past a hundred times. I switched. I’m saving $74/month — $888/year. Same medication. Same dose. Same generic. The only thing different is someone competing for my prescription instead of assuming I’d just keep paying.”
— Representative patient experience based on Script Unlock Nirsevimab bid data. Individual savings vary by zip code, dose, and quantity.
Pharmacies bid to win your Nirsevimab prescription. Prices go lower than any pre-set coupon or discount card — because they’re competing against the pharmacy down the street.
Frequently Asked Questions — Why Nirsevimab Costs So Much
Why is Nirsevimab so expensive in the US?
Nirsevimab is expensive primarily due to patent protection, PBM rebate inflation of list prices, and the absence of federal price negotiation. The US is the only high-income country without regulated or nationally negotiated drug pricing. The same Nirsevimab costs 60–80% less in Canada, the UK, or Australia.
How much should Nirsevimab actually cost?
Script Unlock pharmacy bidding regularly produces Nirsevimab fills at $421/month — close to the floor price most pharmacies can sustainably offer. That's 15% below the standard retail of $495. The manufacturing cost of most small-molecule drugs is a tiny fraction of even this discounted price.
Why has the price of Nirsevimab gone up?
Nirsevimab retail prices have increased approximately 186% over the past decade — from around $173 to $495/month. Drivers include manufacturer list-price hikes, PBM rebate inflation, pharmacy chain consolidation, and the absence of a US price ceiling.
What is the cheapest way to get Nirsevimab?
Cheapest path today: (1) Script Unlock pharmacy bids — avg $421/month. (2) Generic Nirsevimab-alip — typically 70–90% cheaper. (3) 90-day supply — saves ~15% per fill. (4) Manufacturer patient assistance if you qualify. (5) Compare cash to insurance copay — cash is often lower.
Is Nirsevimab cheaper without insurance?
For many patients, yes. Nirsevimab cash via Script Unlock ($421/month) often costs less than the insurance copay — especially on tier 2/3 formulary plans. Compare every fill before paying via insurance.
Does Medicare cover Nirsevimab?
Coverage depends on your specific Part D plan. Nirsevimab is usually covered but tier placement and prior auth vary. In the donut hole (coverage gap), paying cash via Script Unlock ($421/month) is often cheaper than the gap-phase copay. This is legal and allowed — no need to use insurance if the cash price is lower.
Compare Nirsevimab prices now — pharmacies compete
Stop overpaying. Free. 60 seconds. No insurance card. Pharmacies bid on your Nirsevimab prescription.
Stop Overpaying for NirsevimabAverage saving: $74/month · $888/year